Which healthcare stock can dividend investors safely buy? Let's consider two excellent options: AbbVie (NYSE: ABBV) and Amgen (NASDAQ: AMGN).

By exploiting the genetic variation in cancer cells, an already approved cancer drug demonstrated enhanced effects against ...

Immunai Inc., an artificial intelligence biotechnology company, announced on Thursday a multi-year collaboration in ...

Studies suggest that garlic may help prevent and reduce the length of your cold. The evidence is limited, but here’s what to ...

New drugs and therapies have become indispensable for treating an array of cancers. Unfortunately, they can also cause damage to the heart, a side effect that has led to the development of a new ...

Anish Suri, Ph.D., president & chief scientific officer (CSO) of Cue Biopharma, to transition to principal research and immunology advisor BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.

Lilly develops these digital health technologies for global clinical development teams across its focus therapeutic areas of ...

Postdoctoral  Position     A postdoctoral fellow position is immediately available in the laboratory of Dr. Chinyere Iweka in the Department of ...

Agentic AI has the potential to reshape not just healthcare, but the very foundations of biological research. By allowing ...

Johnson & Johnson shows strong progress in oncology with Darzalex sales and regulatory filings, leading to a 'Buy' rating ...

Tharimmune, Inc. (NASDAQ:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced today ...

The scope of research in this field is broad, integrating various disciplines including virology, microbiology, immunology, and bioinformatics. Key areas of interest include: 1. Identification of ...